However, intrahepatic CD56dim NK cells from NAFLD patients displayed significantly increased levels of CD16, NKG2D, CD38, CD69, PD-1, ILT2, TIGIT, and KIR3DL1 compared with normal intrahepatic NK cells (Figure 5B). This evidence concerns the gene CD38 and metabolic dysfunction-associated steatotic liver disease.